Cataract surgery with implantation of a high-add intraocular lens LENTIS® MAX LS-313 MF80 in end-stage, age-related macular degeneration: A case report of magnifying surgery

Andreas F Borkenstein; Eva-Maria Borkenstein

doi:10.1002/ccr3.1912

Cataract surgery with implantation of a high-add intraocular lens LENTIS® MAX LS-313 MF80 in end-stage, age-related macular degeneration: A case report of magnifying surgery

Clin Case Rep. 2018 Nov 13;7(1):74-78. doi: 10.1002/ccr3.1912. eCollection 2019 Jan.

Authors

Andreas F Borkenstein¹, Eva-Maria Borkenstein¹

Affiliation

¹ Borkenstein & Borkenstein, Private Practice Privatklinik der Kreuzschwestern Graz Graz Austria.

Abstract

A new treatment option for cataracts and advanced ARMD: the simultaneous intravitreal injection of anti-vascular endothelial growth factor and implantation of a high-add IOL. We believe major opportunities arise from a new subcategory in cataract surgery-called magnifying surgery (MAGS). Our case proves the potential of this brand-new technology.

Keywords: AMD; ARMD; MAGS; cataract surgery; high‐add intraocular lens; magnifying surgery.

Publication types

Case Reports